SAGE - Sage Therapeutics Inc
IEX Last Trade
8.435
0.345 4.090%
Share volume: 531,209
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.09
0.35
4.27%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-02-16 | 2023-05-02 | 2023-08-07 | 2023-11-07 | 2024-02-14 | 2024-04-25 | 2024-07-31 | |
| Total revenue | 1.739 M | 2.864 M | 3.294 M | 2.474 M | 2.716 M | 77.971 M | 7.902 M | 8.654 M | |
| Cost of revenue | 184.000 K | 143.000 K | 230.000 K | 205.000 K | 905.000 K | 819.000 K | 1.269 M | 1.407 M | |
| Gross profit | 1.555 M | 2.721 M | 3.064 M | 2.269 M | 1.811 M | 77.152 M | 6.633 M | 7.247 M | |
| 74.98% | 12.61% | -25.95% | -20.19% | 4,160.19% | -91.40% | 9.26% | |||
| Operating expenses | 143.035 M | 73.836 M | 158.534 M | 172.726 M | 180.061 M | 119.438 M | 124.308 M | 118.547 M | |
| Selling general and admin | 61.482 M | -15.459 M | 65.708 M | 75.565 M | 78.142 M | 55.109 M | 52.574 M | 55.983 M | |
| Research and development | 81.553 M | 89.295 M | 92.826 M | 97.161 M | 101.919 M | 64.329 M | 71.734 M | 62.564 M | |
| Total expenses | 143.219 M | 158.997 M | 158.764 M | 172.931 M | 180.966 M | 120.257 M | 125.577 M | 119.954 M | |
| 11.02% | -0.15% | 8.92% | 4.65% | -33.55% | 4.42% | -4.48% | |||
| Operating income | -141.480 M | -156.133 M | -155.470 M | -170.457 M | -178.250 M | -42.286 M | -117.675 M | -111.300 M | |
| Ebit | -141.480 M | -156.133 M | -155.470 M | -170.457 M | -178.250 M | -42.286 M | -117.675 M | -111.300 M | |
| Pretax income | -137.323 M | -147.146 M | -146.828 M | -160.325 M | -201.630 M | -32.706 M | -108.483 M | -102.854 M | |
| 7.15% | -0.22% | 9.19% | 25.76% | -83.78% | 231.69% | -5.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -137.323 M | -147.146 M | -146.828 M | -160.325 M | -201.630 M | -32.706 M | -108.483 M | -102.854 M | |
| -7.15% | 0.22% | -9.19% | -25.76% | 83.78% | -231.69% | 5.19% | |||
| Net income | -137.323 M | -147.146 M | -146.828 M | -160.325 M | -201.630 M | -32.706 M | -108.483 M | -102.854 M | |
| -7.15% | 0.22% | -9.19% | -25.76% | 83.78% | -231.69% | 5.19% |